BrainCool AB (publ) (STO:BRAIN)
0.8500
+0.0400 (4.94%)
Jul 6, 2026, 5:29 PM CET
BrainCool AB Earnings Call Transcripts
Fiscal Year 2026
-
PRINCESS 2 and COTTIS 2 are large multicenter trials testing ultra-early brain cooling for cardiac arrest and severe stroke, respectively, using the RhinoChill device. Both studies aim to improve neurological outcomes by initiating cooling during the critical ischemic phase, with interim analyses planned to monitor safety and efficacy.